Drug shortages
HHS proposes policies to prevent drug shortages. Find out how AHA is collaborating with the private sector to mitigate supply chain vulnerabilities.
Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications.
The Drug Enforcement Administration today issued its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.
The National Academies of Sciences, Engineering, and Medicine will host a public workshop Sept. 5-6 on “Medical Product Shortages during Disasters: Opportunities to Predict, Prevent and Respond.”
The American Society of Health-System Pharmacists this week published updated guidelines for managing drug shortages.
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Food and Drug Administration Commissioner Scott Gottlieb, M.D., today announced the formation of a drug shortages task force.
Shortages of intravenous saline and other fluids are beginning to improve, according to the Food and Drug Administration.
A bipartisan group of 31 senators last week urged Food and Drug Administration Commissioner Scott Gottlieb, M.D., to convene the Drug Shortages Task Force created by the FDA Safety and Innovation Act of 2012, stakeholders and other relevant agencies to report on the root causes of drug shortages.
The Food and Drug Administration identified 39 new drug and biological product shortages in 2017, up from 26 in 2016, and 41 ongoing shortages from prior years, according to the agency’s latest annual report on the issue.
The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis.